INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED
領航醫藥及生物科技有限公司
(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)
(Stock Code: 399)
31 July 2020
Dear Non-Registered Shareholder,
Notification of publication of Annual Report 31 March 2020, Circular and Notice for Annual General Meeting to be held on 31 August 2020 on the websites of Innovative Pharmaceutical Biotech Limited ("the Company")
We hereby notify you that the above corporate communications (the "Corporate Communication") of the Company, in both English and Chinese, are now available on the Company's websites at www.ipb.asia and www.irasia.com/listco/hk/ipb.
You may now have access to the Corporate Communication on the Company's websites.
If you wish to receive a printed copy of the Corporate Communication, you can complete the enclosed Request Form and return it to the Company's Hong Kong branch share registrar, Tricor Tengis Limited by post using the mailing label provided. The printed copy of the Corporate Communication will be sent to you free of charge as soon as practicable upon receipt of your Request Form.
Please note that by completing and returning the Request Form to request for the printed copy of the Corporate Communication, you will expressly indicate that you confirm to receive all future Corporate Communication(s) of the Company in printed form.
Should you have any queries relating to this notification, please contact Customer Service Hotline of Tricor Tengis Limited at (852) 2980 1333 from 9:00 a.m. to 6:00 p.m., Monday to Friday (excluding public holidays).
Yours faithfully,
Innovative Pharmaceutical Biotech Limited
Company Secretary
Encl.
Note: Corporate Communication(s) refer to any document issued or to be issued by the Company for information or action of holders of securities of the Company, including but not limited to annual report, summary financial report (where applicable), interim report, summary interim report (where applicable), quarterly report, notice of meeting, listing document and circular.
Request Form
To: Innovative Pharmaceutical Biotech Limited (the "Company")
c/o Tricor Tengis Limited Level 54, Hopewell Centre
183 Queen's Road East, Hong Kong
I/We would like to receive a printed copy of the Annual Report 2020, Circular and Notice for Annual General Meeting to be held on 31 August 2020 and all future Corporate Communication(s)(Note 1) of the Company(Note 2).
Signature: | Date: | |||
Name: | (English) | (Chinese) | ||
(in block letters) | ||||
Contact Phone Number: |
Notes:
- Corporate Communication(s) refer to any document issued or to be issued by the Company for information or action of holders of securities of the Company, including but not limited to annual report, summary financial report (where applicable), interim report, summary interim report (where applicable), quarterly report, notice of meeting, listing document and circular.
- By completing and returning this Request Form to request for the printed copy of the above Corporate Communication, you have expressly indicated that you confirm to receive all future Corporate Communication(s) of the Company in printed form.
Please cut the mailing label and stick this on an envelope
to return the Request Form to us.
No postage stamp is required for local mailing
當 閣下寄回此申請表格時，請將此郵寄標籤剪貼於信封上。
如在本港投寄， 閣下無需支付郵費或貼上郵票
(Please cut along the dotted line)
Mailing Label 郵寄標籤
Tricor Tengis Limited
卓佳登捷時有限公司
Freepost No.簡便回郵號碼：37
Hong Kong 香港
Attachments
- Original document
- Permalink
Disclaimer
Innovative Pharmaceutical Biotech Limited published this content on 30 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2020 10:10:09 UTC
